Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10215-10223
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10215
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10215
Table 2 Changes of deduced fibrosis stages by interferon plus ribavirin therapy
| SVRs | Relapsers | NVRs | |
| (n = 13) | (n = 12) | (n = 16) | |
| 2-point reduction | 9 (69.2) | 2 (16.7) | 0 |
| 1-point reduction | 2 (15.4) | 1 (8.3) | 5 (31.3) |
| No changes | 2 (15.4) | 6 (50.0) | 9 (56.2) |
| 1-point progression | 0 | 3 (25.0) | 2 (12.5) |
| Interval (yr) | 2.0 (1.0-2.5) | 2.8 (1.7-3.1) | 1.6 (0.7-2.4) |
- Citation: Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Shibata A, Asada W, Kawabe N, Hashimoto S, Murao M, Nakano T, Shimazaki H, Kan T, Nakaoka K, Takagawa Y, Ohki M, Kurashita T, Takamura T, Yoshioka K. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. World J Gastroenterol 2015; 21(35): 10215-10223
- URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10215.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10215